The Pesky Toad

The Toad's Take: Tech, Macro, & Pescadero Life

Reality Check Toad's Satire Survival Guide Community Hub Reading Stack Back to The Take

news Scmp World 2026-08-27

China's Akeso cancer drug outperforms AstraZeneca's Imfinzi in trial

Chinese biopharma company Akeso reported its immunotherapy drug showed superior results to AstraZeneca’s Imfinzi in a phase-three biliary cancer trial.

Read Original Story →

Share on Facebook WhatsApp

Support Your Local Toad

The Pesky Toad is free and ad-light. If you find it useful, toss a few pesos in the tip jar to help keep the servers running and the satire flowing.